# Instituto Nacional de Cancer, Brazil: Phase 1 study completed, 20 enrolled (Head and Neck Neoplasms, Mucositis Oral)

**Score:** 30/100

| Field | Value |
|---|---|
| Sponsor | Instituto Nacional de Cancer, Brazil |
| Sponsor type | Non-US government |
| Study | Safety and Tolerability of the Use of Copaiba in Patients With Oral Cancer Submitted to Radiotherapy |
| NCT ID | NCT05308732 |
| Phase | Phase 1 |
| Status | completed |
| Conditions | Head and Neck Neoplasms; Mucositis Oral; Radiotherapy; Complications |
| Intervention types | drug |
| Target enrollment | 20 |
| Site countries | Brazil |
| Posted | 2022-04-04 |
| Planned start | 2021-05-11 |
| Event | Completed |
| Event date | 2026-09-30 |
| Last update posted | 2026-10-13 |

## Why this score
- Completed: closeout, analysis and the next study ahead.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT05308732). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.